RecruitingPhase 2NCT06638931
Agnostic Therapy in Rare Solid Tumors
Studying Parathyroid carcinoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Instituto do Cancer do Estado de São Paulo
- Principal Investigator
- Camila MV Moniz, DoctorOncologist
- Intervention
- Nivolumab(drug)
- Enrollment
- 28 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2024 – 2028
Study locations (8)
- DF Star, Brasília, Brasília, Brazil
- Hospital São Carlos, Fortaleza, Ceará, Brazil
- Hospital São Rafael, Salvador, Estado de Bahia, Brazil
- Hospital Santa Cruz, Curitiba, Paraná, Brazil
- IDOR Recife, Recife, Pernambuco, Brazil
- Instituto D'Or de Pesquisa e Ensino, Rio de Janeiro, Rio de Janeiro, Brazil
- Instituto D'or de Pesquisa e Ensino, São Paulo, São Paulo, Brazil
- Instituto do Câncer do Estado de São Paulo - ICESP, São Paulo, São Paulo, Brazil
Collaborators
Financiadora de Estudos e Projetos
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06638931 on ClinicalTrials.govOther trials for Parathyroid carcinoma
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06645951Institution of an Italian Multicenter Database of Patients with Parathyroid Carcinoma or Atypical Parathyroid AdenomaF.I.R.M.O. - Fondazione Italiana Ricerca sulle Malattie dell'Osso - Ente del Terzo Settore
- RECRUITINGNANCT06835426High-resolution PET-CT Specimen Imaging for the Perioperative Visualization of Resection MarginsAlgemeen Ziekenhuis Maria Middelares
- RECRUITINGNCT04969926Natural History Study of Parathyroid DisordersNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)